HD IL-2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HD IL-2, covering 2021-02-01 to 2023-12-05. Get the full timeline:
Most recent: Clinical Trial Update: HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma [Phase 4]